Fortress Biotech, Inc.·4

Apr 29, 4:20 PM ET

Lorenz Kevin 4

4 · Fortress Biotech, Inc. · Filed Apr 29, 2022

Insider Transaction Report

Form 4
Period: 2022-01-01
Lorenz Kevin
Director
Transactions
  • Award

    COMMON STOCK, PAR VALUE $0.001

    2022-01-01+50,000264,572 total
Holdings
  • COMMON STOCK, PAR VALUE $0.001

    (indirect: By Spouse)
    10,000
Footnotes (1)
  • [F1]One-third of the shares will vest on each of January 1, 2023, 2024 and 2025, subject to continued service.

Documents

1 file
  • 4
    tm2213913-5_4seq1.xmlPrimary

    OWNERSHIP DOCUMENT